Dorzolamide Hydrochloride Timolol Maleate Solution/ Drops
Product Images NDC 71921-226

9 FDA label images from Florida Pharmaceutical Products, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Dorzolamide Hydrochloride Timolol Maleate (NDC 71921-226). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Florida Pharmaceutical Products, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dorzolamide (Dorzolamide)

Dorzolamide (Dorzolamide)
Chemical structure of dorzolamide hydrochloride, the active ingredient shown in the image. The diagram illustrates the molecular configuration, including sulfonamide and thiophene groups with associated bonds and atoms.*
FDA Label Image

Timolol1 (Timolol1)

Timolol1 (Timolol1)
Chemical structure diagram showing molecular components of dorzolamide hydrochloride timolol maleate, the active ingredients in the ophthalmic solution product by Florida Pharmaceutical Products, LLC.*
FDA Label Image
FDA Label Image

Figure-a (Figure A)

Figure-a (Figure A)
An instructional illustration labeled Figure A showing a hand holding an eye drop bottle positioned above an eye, demonstrating how to administer ophthalmic solution eye drops by placing a drop into the lower eyelid.*
FDA Label Image

Figure-b (Figure B)

Figure-b (Figure B)
An instructional illustration showing the proper technique for instilling ophthalmic solution drops into the eye. It depicts a hand holding a dropper bottle above an eye while another hand pulls down the lower eyelid to create a pocket for the drops.*
FDA Label Image

Dorzo-timo-container-1 (Dorzo Timo Container 1)

Dorzo-timo-container-1 (Dorzo Timo Container 1)
Label for Dorzolamide HCl/Timolol Maleate ophthalmic solution USP, 22.3 mg/6.8 mg per mL, 10 mL bottle. Manufactured for Florida Pharmaceutical Products, LLC and by Indoco Remedies Limited, India. Includes dosage strength, NDC 71921-226-10, usage instructions for eye use only, barcode, lot and expiration placeholders, and contact information.*
FDA Label Image

Dorzo-timo-carton-1 (Dorzo Timo Carton 1)

Dorzo-timo-carton-1 (Dorzo Timo Carton 1)
Packaging label for Dorzolamide HCl/Timolol Maleate ophthalmic solution, USP sterile drops. The label states a concentration of 22.3 mg/6.8 mg per mL and volume of 10 mL. It features dosage and storage information, including preservatives and inactive ingredients. Manufactured by Florida Pharmaceutical Products, LLC and Indoco Remedies Ltd., with NDC 71921-226-10. The package includes barcodes, handling instructions, and a caution that it is for eye use only.*
FDA Label Image

Dorzo-timo-container-2 (Dorzo Timo Container 2)

Dorzo-timo-container-2 (Dorzo Timo Container 2)
Label for Dorzolamide HCl/Timolol Maleate ophthalmic solution, USP, containing 22.3 mg/6.8 mg per mL. The 10 mL prescription eye drop solution is manufactured for Florida Pharmaceutical Products, LLC and by Gland Pharma Limited, India. Label includes dosage strength, NDC 71921-226-10, usage instructions, and contact information.*
FDA Label Image

Dorzo-timo-carton-2 (Dorzo Timo Carton 2)

Dorzo-timo-carton-2 (Dorzo Timo Carton 2)
Packaging label for Dorzolamide Hydrochloride Timolol Maleate ophthalmic solution, USP with strength 22.3 mg/6.8 mg per mL. The label states it is sterile, for use in the eyes only, and available in a 10 mL bottle. Manufactured for Florida Pharmaceutical Products, LLC and by Gland Pharma Limited in Hyderabad, India. Includes dosage, storage, and precautionary information, and features the NDC 71921-226-10.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.